Charles Schwab Investment Management Inc. Has $16.09 Million Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)
Charles Schwab Investment Management Inc. boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 3.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 648,945 shares of the company’s stock after purchasing an additional 19,453 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Beam Therapeutics were worth […]
